Saurav Das, Armand Russo. "Real world treatment outcome with azacytidine (AZA)-tocilizumab (TCZ) for reducing steroid dependence in vexas syndrome with myelodysplastic syndrome (MDS): A single-center, 1.5-year longitudinal observational study." Blood, 2025. doi:10.1182/blood-2025-6695